Daiwa Securities Group Inc. Bei Gene, Ltd. Transaction History

Daiwa Securities Group Inc.

$21.6 Billion
Q3 2024

A detailed history of Daiwa Securities Group Inc. transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 158 shares of BGNE stock, worth $30,539. This represents 0.0% of its overall portfolio holdings.

Number of Shares

158

Previous 158 -0.0%

Holding current value

$30,539

Previous $23,000 52.17%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 02, 2024	SELL	$141.8 - $181.47 $1,985 - $2,540	-14 Reduced 8.14%	158 $25,000
Q4 2023 Jan 31, 2024	SELL	$158.67 - $201.58 $183,581 - $233,228	-1,157 Reduced 87.06%	172 $31,000
Q3 2023 Nov 01, 2023	BUY	$179.87 - $225.13 $81,301 - $101,758	452 Added 51.54%	1,329 $239,000
Q2 2023 Jul 31, 2023	BUY	$178.3 - $266.78 $126,593 - $189,413	710 Added 425.15%	877 $157,000
Q1 2023 May 02, 2023	SELL	$215.53 - $274.5 $5,388 - $6,862	-25 Reduced 13.02%	167 $36,000
Q4 2022 Feb 06, 2023	BUY	$125.51 - $229.3 $1,129 - $2,063	9 Added 4.92%	192 $42,000
Q2 2022 Aug 09, 2022	BUY	$121.11 - $216.05 $4,602 - $8,209	38 Added 26.21%	183 $30,000
Q1 2022 Apr 29, 2022	SELL	$146.52 - $269.56 $304,175 - $559,606	-2,076 Reduced 93.47%	145 $27,000
Q4 2021 Feb 03, 2022	BUY	$248.56 - $389.34 $280,127 - $438,786	1,127 Added 103.02%	2,221 $601,000
Q3 2021 Nov 05, 2021	SELL	$249.6 - $403.14 $20,217 - $32,654	-81 Reduced 6.89%	1,094 $397,000
Q2 2021 Aug 06, 2021	BUY	$292.75 - $367.01 $39,228 - $49,179	134 Added 12.87%	1,175 $403,000
Q1 2021 May 03, 2021	BUY	$260.64 - $382.12 $248,129 - $363,778	952 Added 1069.66%	1,041 $362,000
Q4 2020 Feb 04, 2021	SELL	$221.31 - $316.61 $431,997 - $618,022	-1,952 Reduced 95.64%	89 $23,000
Q3 2020 Nov 02, 2020	BUY	$189.18 - $286.44 $39,160 - $59,293	207 Added 11.29%	2,041 $585,000
Q1 2020 May 14, 2020	SELL	$121.84 - $173.19 $35,820 - $50,917	-294 Reduced 13.82%	1,834 $226,000
Q4 2019 Jan 31, 2020	SELL	$115.78 - $208.34 $3,357 - $6,041	-29 Reduced 1.34%	2,128 $353,000
Q3 2019 Nov 04, 2019	BUY	$120.61 - $148.29 $13,267 - $16,311	110 Added 5.37%	2,157 $264,000
Q1 2019 Apr 26, 2019	SELL	$122.82 - $151.83 $982 - $1,214	-8 Reduced 0.39%	2,047 $270,000
Q4 2018 Feb 05, 2019	BUY	$107.01 - $175.15 $199,038 - $325,779	1,860 Added 953.85%	2,055 $288,000
Q2 2018 Jul 30, 2018	SELL	$152.5 - $216.77 $825,635 - $1.17 Million	-5,414 Reduced 96.52%	195 $30,000
Q1 2018 May 02, 2018	BUY	$97.41 - $177.22 $546,372 - $994,026	5,609 New	5,609 $942,000

Others Institutions Holding BGNE

# of Institutions

244

Shares Held

45.3M

Call Options Held

258K

Put Options Held

52.2K

View Full List

About BeiGene, Ltd.

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $20B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

More about BGNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Daiwa Securities Group Inc. with notifications on news.

Account

Daiwa Securities Group Inc. Bei Gene, Ltd. Transaction History